Literature DB >> 31600451

MicroRNA-1298-5p inhibits cell proliferation and the invasiveness of bladder cancer cells via down-regulation of connexin 43.

Gang Li1, Longfeng Sun2, Zhongyi Mu1, Shibo Liu1, Hongchen Qu1, Qingpeng Xie1, Bin Hu1.   

Abstract

MicroRNA (miR)-1298 is widely down-regulated in a variety of malignant tumors, which facilitates cell proliferation, invasiveness, and migration. However, the specific biological function of miR-1298 in bladder cancer (BC) is still unknown. Connexin 43 (Cx43) is often up-regulated in tumors. Identifying miRNAs that target Cx43 in the setting of BC will help to develop Cx43-based therapies for BC. In this study, the results demonstrated that the expression levels of miR-1298 and Cx43 were significantly down-regulated and up-regulated, respectively, in BC tissues. Overexpression of miR-1298 inhibited cell proliferation, migration, and invasiveness in two BC cell lines as determined using MTT assays, cell cycle assays, colony formation assays, Transwell assays, gelatin zymography, and Western blot. In addition, we found that miR-1298 decreased Cx43 expression by directly targeting the 3'-UTR. Further, we observed that the promotion of BC cell proliferation, migration, and invasiveness from Cx43 on could be partially attenuated by overexpressing miR-1298. Moreover, the protein expression of p-ERK was ameliorated after transfection with overexpressed-miR-1298. Knockdown of Cx43 reversed the promotion of cell migration and invasiveness due to decreased expression of miR-1298. All of the data from our study indicate that miR-1298 could be a diagnostic marker of BC and a potential therapeutic agent via inhibiting Cx43.

Entities:  

Keywords:  bladder cancer; cancer de la vessie; connexin 43; connexine 43; invasion; invasiveness; microARN-1298-5p; microRNA-1298-5p; proliferation; prolifération

Mesh:

Substances:

Year:  2019        PMID: 31600451     DOI: 10.1139/bcb-2019-0137

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  8 in total

1.  Inhibition of miR-1298-5p attenuates sepsis lung injury by targeting SOCS6.

Authors:  Jian Ma; Li-Yun Xu; Qiu-Hong Sun; Xiao-Yu Wan
Journal:  Mol Cell Biochem       Date:  2021-06-07       Impact factor: 3.396

2.  MicroRNA-1298-3p inhibits proliferation and invasion of glioma cells by downregulating Nidogen-1.

Authors:  Xiaohe Xu; Yunchao Ban; Zilong Zhao; Qichen Pan; Jingyu Zou
Journal:  Aging (Albany NY)       Date:  2020-04-30       Impact factor: 5.682

3.  MicroRNA-1298 is downregulated in non-small cell lung cancer and suppresses tumor progression in tumor cells.

Authors:  Zhonghai Du; Jun Wu; Juan Wang; Yan Liang; Sensen Zhang; Zhimei Shang; Wenchao Zuo
Journal:  Diagn Pathol       Date:  2019-12-04       Impact factor: 2.644

4.  microRNA-1298 inhibits the malignant behaviors of breast cancer cells via targeting ADAM9.

Authors:  Weili Chen; Qing Lu; Siyu Li; Xinyue Zhang; Xiaohong Xue
Journal:  Biosci Rep       Date:  2020-12-23       Impact factor: 3.840

5.  HIF-1α promotes the proliferation and migration of pulmonary arterial smooth muscle cells via activation of Cx43.

Authors:  Xiao-Jian Han; Wei-Fang Zhang; Qin Wang; Min Li; Chun-Bo Zhang; Zhang-Jian Yang; Ren-Jie Tan; Li-Jun Gan; Le-Ling Zhang; Xue-Mei Lan; Fang-Lin Zhang; Tao Hong; Li-Ping Jiang
Journal:  J Cell Mol Med       Date:  2021-10-26       Impact factor: 5.310

6.  Overexpression of miR-1298 attenuates myocardial ischemia-reperfusion injury by targeting PP2A.

Authors:  Chun Ouyang; Lei Huang; Xiaoqiang Ye; Mingming Ren; Zhen Han
Journal:  J Thromb Thrombolysis       Date:  2021-08-05       Impact factor: 2.300

7.  Circular RNA TAF4B Promotes Bladder Cancer Progression by Sponging miR-1298-5p and Regulating TGFA Expression.

Authors:  Xiaoting Zhang; Xiaofeng Li; Xian Fu; Mengli Yu; Guicheng Qin; Guihong Chen; Chenchen Huang
Journal:  Front Oncol       Date:  2021-07-12       Impact factor: 6.244

8.  Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer.

Authors:  Hongjun Guan; Changpeng Sun; Yinfeng Gu; Jinjin Li; Jie Ji; Yongxian Zhu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.